Pasithea Therapeutics (KTTA) Acquisitions (2022)
Pasithea Therapeutics (KTTA) posted Acquisitions of $2.2 million for Q4 2022, up 10881.77% sequentially from $20481.0 in Q3 2022.
Pasithea Therapeutics (KTTA) Acquisitions (2022) Analysis & Trends
Pasithea Therapeutics has reported Acquisitions for 1 years, with the latest figure at $2.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | - |
| 10 | Pasithea Therapeutics | 15.55 Mn | 15.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 20,481.00 |